Literature DB >> 21159922

Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India.

Kamlesh Gidwani1, Albert Picado, Bart Ostyn, Shri Prakash Singh, Rajiv Kumar, Basudha Khanal, Veerle Lejon, François Chappuis, Marleen Boelaert, Shyam Sundar.   

Abstract

The persistence of anti-Leishmania donovani antibodies in past visceral leishmaniasis (VL) cases was retrospectively assessed by means of the direct agglutination test (DAT) and the rK39 enzyme-linked immunosorbent assay (ELISA). Antibody titers remained high for an extended period of time in past cases of VL. These results highlight the need to carefully elicit the history of patients with VL symptoms.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21159922      PMCID： PMC3067357          DOI： 10.1128/CVI.00473-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  16 in total

1.  Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible & operationally achievable.

Authors:  S K Bhattacharya; Dipika Sur; P K Sinha; Juntra Karbwang
Journal:  Indian J Med Res       Date:  2006-03       Impact factor: 2.375

2.  Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DAT/VL).

Authors:  Diane Jacquet; Marleen Boelaert; Jill Seaman; Suman Rijal; Shyam Sundar; Joris Menten; Eddy Magnus
Journal:  Trop Med Int Health       Date:  2006-12       Impact factor: 2.622

3.  Immunologic tests in patients after clinical cure of visceral leishmaniasis.

Authors:  Luciana De Almeida Silva; Héctor Dardo Romero; Aluízio Prata; Roberto Teodoro Costa; Evaldo Nascimento; Sílvio Fernandes Guimarães Carvalho; Virmondes Rodrigues
Journal:  Am J Trop Med Hyg       Date:  2006-10       Impact factor: 2.345

4.  Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India.

Authors:  S P Singh; D C S Reddy; M Rai; S Sundar
Journal:  Trop Med Int Health       Date:  2006-06       Impact factor: 2.622

5.  Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen.

Authors:  Sarman Singh; Veena Kumari; Niti Singh
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

6.  Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh.

Authors:  K M Kurkjian; L E Vaz; R Haque; C Cetre-Sossah; S Akhter; S Roy; F Steurer; J Amann; M Ali; R Chowdhury; Y Wagatsuma; J Williamson; S Crawford; R F Breiman; J H Maguire; C Bern; W E Secor
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

7.  Pre- and post-treatment antibody levels in visceral leishmaniasis.

Authors:  A Hailu
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Sep-Oct       Impact factor: 2.184

8.  Serological markers for leishmania donovani infection in Nepal: Agreement between direct agglutination test and rK39 ELISA.

Authors:  Basudha Khanal; Suman Rijal; Bart Ostyn; Albert Picado; Kamlesh Gidwani; Joris Menten; Diane Jacquet; Veerle Lejon; Francois Chappuis; Marleen Boelaert
Journal:  Trop Med Int Health       Date:  2010-11       Impact factor: 2.622

9.  rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection.

Authors:  E E Zijlstra; N S Daifalla; P A Kager; E A Khalil; A M El-Hassan; S G Reed; H W Ghalib
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

Review 10.  The regulation of immunity to Leishmania major.

Authors:  S L Reiner; R M Locksley
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527
View more
  36 in total

1.  Identification and characterization of a novel Leishmania donovani antigen for serodiagnosis of visceral leishmaniasis.

Authors:  Subodh Kumar; Dinesh Kumar; Jaya Chakravarty; Madhukar Rai; Shyam Sundar
Journal:  Am J Trop Med Hyg       Date:  2012-04       Impact factor: 2.345

Review 2.  Diagnosis of visceral leishmaniasis: developments over the last decade.

Authors:  Gurumurthy Srividya; Arpita Kulshrestha; Ruchi Singh; Poonam Salotra
Journal:  Parasitol Res       Date:  2011-11-09       Impact factor: 2.289

3.  A Correlative Study of Splenic Parasite Score and Peripheral Blood Parasite Load Estimation by Quantitative PCR in Visceral Leishmaniasis.

Authors:  Medhavi Sudarshan; Toolika Singh; Jaya Chakravarty; Shyam Sundar
Journal:  J Clin Microbiol       Date:  2015-12       Impact factor: 5.948

4.  Evaluation of a hypothetical protein for serodiagnosis and as a potential marker for post-treatment serological evaluation of tegumentary leishmaniasis patients.

Authors:  Mariana Pedrosa Lima; Lourena Emanuele Costa; Mariana Costa Duarte; Daniel Menezes-Souza; Beatriz Cristina Silveira Salles; Thaís Teodoro de Oliveira Santos; Fernanda Fonseca Ramos; Miguel Angel Chávez-Fumagalli; Amanda Christine Silva Kursancew; Roberta Passamani Ambrósio; Bruno Mendes Roatt; Ricardo Andrez Machado-de-Ávila; Denise Utsch Gonçalves; Eduardo Antonio Ferraz Coelho
Journal:  Parasitol Res       Date:  2017-02-01       Impact factor: 2.289

5.  Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment.

Authors:  M S Duthie; J Guderian; A Vallur; A Bhatia; P Lima dos Santos; E Vieira de Melo; A Ribeiro de Jesus; M Todt; D Mondal; R Almeida; S G Reed
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-31       Impact factor: 3.267

6.  Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasis.

Authors:  A C Vallur; A Hailu; D Mondal; C Reinhart; H Wondimu; Y Tutterrow; H W Ghalib; S G Reed; M S Duthie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-19       Impact factor: 3.267

7.  Comparison of point-of-care tests for the rapid diagnosis of visceral leishmaniasis in East African patients.

Authors:  Asrat Bezuneh; Maowia Mukhtar; Asim Abdoun; Tedla Teferi; Yegnasew Takele; Ermias Diro; Asfaw Jemaneh; Welelta Shiferaw; Hirut Wondimu; Ajay Bhatia; Randall F Howard; Hashim Ghalib; Gregory C Ireton; Asrat Hailu; Steven G Reed
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

8.  Diagnosis of Visceral Leishmaniasis Using Peripheral Blood Microscopy in Ethiopia: A Prospective Phase-III Study of the Diagnostic Performance of Different Concentration Techniques Compared to Tissue Aspiration.

Authors:  Ermias Diro; Cedric P Yansouni; Yegnasew Takele; Bewketu Mengesha; Lutgarde Lynen; Asrat Hailu; Johan van Griensven; Marleen Boelaert; Philippe Büscher
Journal:  Am J Trop Med Hyg       Date:  2016-10-31       Impact factor: 2.345

9.  Changing epidemiology of visceral leishmaniasis in northeastern Brazil: a 25-year follow-up of an urban outbreak.

Authors:  Ádila L M Lima; Iraci D de Lima; José F V Coutinho; Úrsula P S T de Sousa; Marcos A G Rodrigues; Mary E Wilson; Richard D Pearson; José W Queiroz; Selma M B Jerônimo
Journal:  Trans R Soc Trop Med Hyg       Date:  2017-10-01       Impact factor: 2.184

10.  Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis.

Authors:  A C Vallur; M S Duthie; C Reinhart; Y Tutterrow; S Hamano; K R H Bhaskar; R N Coler; D Mondal; S G Reed
Journal:  Clin Microbiol Infect       Date:  2013-11-18       Impact factor: 8.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.